We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TMDX market cap is 3.5B. The company's latest EPS is USD -0.7650 and P/E is -123.05.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25.68M | 31.38M | 41.55M | 52.47M | 66.43M |
| Operating Income | -5.54M | -6.78M | -2.09M | -906k | -28.34M |
| Net Income | -7.43M | -6.72M | -2.64M | -1M | -25.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.6M | 25.64M | 30.26M | 93.46M | 241.62M |
| Operating Income | -29.6M | -26.38M | -39.43M | -31.44M | -28.73M |
| Net Income | -33.55M | -28.75M | -44.22M | -36.23M | -25.03M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 274.87M | 277.15M | 287.09M | 690.36M | 689.23M |
| Total Liabilities | 87.02M | 89.77M | 94.46M | 545.15M | 562.77M |
| Total Equity | 187.86M | 187.38M | 192.63M | 145.21M | 126.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 105.3M | 152.03M | 134.89M | 277.15M | 706.05M |
| Total Liabilities | 50.65M | 48.14M | 67.04M | 89.77M | 568.85M |
| Total Equity | 54.65M | 103.89M | 67.85M | 187.38M | 137.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41.78M | -45.82M | -8.66M | -14.46M | -21.33M |
| Investing | 57.28M | 54.51M | -927k | -2.31M | -152.14M |
| Financing | 164.86M | 167.93M | 3.96M | 397.97M | 399.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.29M | -30.27M | -28.86M | -45.82M | -13.03M |
| Investing | -60.5M | -41.6M | 29.27M | 54.51M | -193.95M |
| Financing | 92.72M | 75.55M | 1.39M | 167.93M | 400.42M |
| Market Cap | 3.5B |
| Price to Earnings Ratio | -123.05 |
| Price to Sales Ratio | 12.75 |
| Price to Cash Ratio | 7.8 |
| Price to Book Ratio | 22.44 |
| Dividend Yield | - |
| Shares Outstanding | 32.72M |
| Average Volume (1 week) | 693.45k |
| Average Volume (1 Month) | 871.16k |
| 52 Week Change | 35.27% |
| 52 Week High | 99.63 |
| 52 Week Low | 36.4201 |
| Spread (Intraday) | 1.3 (1.21%) |
| Company Name | TransMedics Group Inc |
| Address |
200 minuteman road andover, massachusetts 01810 |
| Website | https://www.transmedics.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
